AVBP News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-12 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 1.01,2.02,9.01. |
| 2026-06-22 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 5.07. |
| 2026-05-11 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-05-11 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-03-17 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2026-03-05 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-11-10 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-09-09 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2025-08-11 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-07-21 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-07-02 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2025-06-23 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2025-06-20 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-12 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-04-28 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2025-03-13 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 4.01,9.01. |
| 2025-03-03 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-01-22 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 1.01,7.01,9.01. |
| 2024-11-14 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-09-09 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2024-08-14 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-07-09 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K/A | ArriVent BioPharma, Inc. filed Form 8-K/A covering items 5.02,9.01. |
| 2024-07-09 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K/A | ArriVent BioPharma, Inc. filed Form 8-K/A covering items 5.02. |
| 2024-06-05 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 1.01,7.01,9.01. |
| 2024-05-16 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2024-05-08 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-04-22 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2024-03-28 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-01-30 | Current report | SEC filing | ArriVent BioPharma, Inc. filed Form 8-K | ArriVent BioPharma, Inc. filed Form 8-K covering items 5.03,8.01,9.01. |